Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson Explores Sale of Cerenovus for $1 Billion

February 16, 2025
According to reports, pharmaceutical giant Johnson & Johnson is looking to sell its stroke care business, Cerenovus, for a staggering $1 billion. The company is said to be focusing on its core business areas and streamlining its operations. Cerenovus, which develops devices for the treatment of stroke, has been struggling in recent years, facing market challenges and regulatory hurdles. This move is seen as a strategic decision by Johnson & Johnson to divest from non-core businesses and invest in areas with higher growth potential. Experts suggest that this sale could attract significant interest from potential buyers in the medical technology sector. For investors looking to capitalize on this opportunity, it is recommended to seek professional advice and consider the forecasted movement of Johnson & Johnson's stock by industry experts from Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for JNJ

Related data

JNJJuly 14, 2025Johnson & Johnson Innovates with New Product Launches  ~1 min.

Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....

JNJFebruary 28, 2025Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations  ~1 min.

Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....

JNJFebruary 26, 2025The surgical devices I design for JJ speed healing and save lives  ~1 min.

Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....

JNJFebruary 18, 2025Johnson & Johnson reportedly wants to sell Cerenovus for 1B  ~1 min.

According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars....

GSKJanuary 2, 2025GSK PLC introduces groundbreaking technology to revolutionize healthcare industry  ~2 min.

GSK PLC, a leading pharmaceutical company, has unveiled its latest innovation aimed at transforming the healthcare industry....

AZNJanuary 1, 2025New breakthrough in medical research announced by AstraZeneca PLC AZN  ~2 min.

Leading pharmaceutical company AstraZeneca PLC AZN has made a groundbreaking discovery in the field of medical research....

REGNJanuary 24, 2025Regeneron Pharmaceuticals, Inc. Announces Positive Results from Clinical Trial of its Breakthrough Drug  ~1 min.

Regeneron Pharmaceuticals, Inc., a leading biotechnology company, has recently announced positive results from a clinical trial of its groundbreaking drug....

LLYDecember 1, 2024Eli Lilly and Company Invests $4.5 Billion in New Medicine Foundry for Advanced Drug Manufacturing  ~2 min.

Eli Lilly and Company, a leading pharmaceutical company, has recently announced a massive investment of $4.5 billion in the establishment of a state-of-the-art medicine foundry....

BMYDecember 10, 2024Bristol-Myers Squibb Announces Groundbreaking Cancer Treatment  ~2 min.

Bristol-Myers Squibb, a renowned pharmaceutical company, has recently announced a groundbreaking cancer treatment that has shown promising results in clinical trials....